Exploring the Safety, Efficacy, and Bioactivity of Herbal Medicines: Bridging Traditional Wisdom and Modern Science in Healthcare

Abstract

This review explores the convergence of traditional wisdom and modern science in the realm of herbal medicines, focusing on the safety, efficacy, and bioactivity of these natural remedies in contemporary healthcare. The rich history of herbal medicines, deeply embedded in cultural traditions, is witnessing a resurgence as the quest for holistic and personalized healthcare gains momentum. Herbal medicine, a time-honored practice passed down through generations, is experiencing renewed interest amid the growing acknowledgment of its potential benefits. This review delves into the safety profiles of herbal remedies, subjecting them to rigorous scientific scrutiny. Additionally, it investigates the efficacy of herbal interventions, aiming to bridge the gap between historical anecdotes and empirical research. The complex bioactivity of herbal compounds, often containing numerous active ingredients, is a focal point, unraveling the mechanisms through which these natural substances interact with the human body. In a world where the synthesis of traditional wisdom and modern science holds promise for advancing healthcare, this review contributes to the ongoing dialogue. By critically examining the safety, efficacy, and bioactivity of herbal remedies, it aims to illuminate the evolving landscape of herbal medicine. The goal is to integrate the best of both worlds to enhance global well-being, acknowledging the potential of herbal medicine as a valuable complement to modern healthcare practices.

Keywords

Herbal medicine / Safety / Efficacy / Bioactivity / Natural remedies / Tradi-tional medicine / Botanical supplements

Acknowledgments

The authors are grateful to revered Swami Ramdev Ji for his im-mense support and guidance. The authors also acknowledge the help and support provided by Patanjali Herbal Research Depart-ment, Patanjali Research Foundation, Haridwar, India. In addi-tion, the authors are also grateful to Mr. Sunil Kumar for provid-ing graphical assistance with this manuscript. The authors are also thankful to the Ministry of AYUSH under the Grant-in-Aid for the Establishment of the Centre of Excellence of Renovation and Upgradation of Patanjali Ayurveda Hospital, Haridwar.

Funding

This study was supported by the Ministry of Ayush, Government of India, under Ayurswasthya Yojana-3988.

Conflict of interest

The authors have no conflict of interests related to this publication.

Author contributions

Study concept and design (AB), acquisition of data (SS, AK), analysis and interpretation of data, drafting of the manuscript (DS, NS), critical revision of the manuscript for important intellectual content (NS), administrative, and study supervision (VA). All au-thors have made a significant contribution to this study and have approved the final manuscript.

References

[1] Aware CB, Patil DN, Suryawanshi SS, Mali PR, Rane MR, Gurav RG, et al. Natural bioactive products as promising therapeutics: A review of natural product-based drug development. S Afr J Bot 2022; 151:512-528. doi:10.1016/j.sajb.2022.05.028.

[2] Islam SU, Dar TUH, Khuroo AA, Bhat BA, Mangral ZA, Tariq L, et al. DNA barcoding aids in identification of adulterants of Trillium govani-anum Wall. ex D. Don. J Appl Res Med Aromat Plants 2021;23:100305. doi:10.1016/j.jarmap.2021.100305.

[3] Jităreanu A, Trifan A, Vieriu M, Caba IC, Mârțu I, Agoroaei L. Current trends in toxicity assessment of herbal medicines: A narrative review. Processes 2022; 11(1):83. doi:10.3390/pr11010083.

[4] Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S. Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol 2015; 4(3):217-220. doi:10.5455/jice.20150623090040,PMID:26401410.

[5] Peltzer K, Pengpid S. The use of herbal medicines among chronic disease patients in Thailand: a cross-sectional survey. J Multidiscip Healthc 2019; 12:573-582. doi:10.2147/JMDH.S212953,PMID:31413584.

[6] Tnah LH, Lee SL, Tan AL, Lee CT, Ng KK, Ng CH, et al. DNA barcode database of common herbal plants in the tropics: a resource for herbal product authentication. Food control 2019; 95:318-326. doi:10.1016/j.foodcont.2018.08.022.

[7] Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal me-dicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010; 243(2):198-216. doi:10.1016/j.taap.2009.12.005,PMID:20018204.

[8] Brantley SJ, Argikar AA, Lin YS, Nagar S, Paine MF. Herb-drug interac-tions: challenges and opportunities for improved predictions. Drug Metab Dispos 2014; 42(3):301-317. doi:10.1124/dmd.113.055236,PMID:24335390.

[9] Singh S, Bansal A, Singh V, Chopra T, Poddar J. Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus. J Diabetes Metab Disord 2022; 21(1):941-950. doi:10.1007/s40200-021-00943-8,PMID:35673446.

[10] Roy A, Khan A, Ahmad I, Alghamdi S, Rajab BS, Babalghith AO, et al. Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications. Biomed Res Int 2022; 2022:5445291. doi:10.1155/2022/5445291,PMID:35707379.

[11] Riaz M, Khalid R, Afzal M, Anjum F, Fatima H, Zia S, et al. Phytobio-active compounds as therapeutic agents for human diseases: A re-view. Food Sci Nutr 2023; 11(6):2500-2529. doi:10.1002/fsn3.3308,PMID:37324906.

[12] Fernández-Ochoa Á, Leyva-Jiménez FJ, De la Luz Cádiz-Gurrea M, Pi-mentel-Moral S, Segura-Carretero A. The Role of High-Resolution An-alytical Techniques in the Development of Functional Foods. Int J Mol Sci 2021; 22(6):3220. doi:10.3390/ijms22063220,PMID:33809986.

[13] Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bi-oactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 2019; 20(6):353-367. doi:10.1038/s41580-019-0108-4,PMID:30814649.

[14] Fu Y, Yang JC, Cunningham AB, Towns AM, Zhang Y, Yang HY, et al. A billion cups: The diversity, traditional uses, safety issues and po-tential of Chinese herbal teas. J Ethnopharmacol 2018; 222:217-228. doi:10.1016/j.jep.2018.04.026,PMID:29730132.

[15] Zhao J, Deng JW, Chen YW, Li SP. Advanced phytochemical analysis of herbal tea in China. J Chromatogr A 2013; 1313:2-23. doi:10.1016/j.chroma.2013.07.039, PMID:23906802.

[16] Dori D, Méda N, Gbaguidi FA, Quetin-Leclercq J, Semdé R. [ Whole-sale distribution and delivery of plant-based medicinal products through the pharmaceutical system of Burkina Faso]. Ann Pharm Fr 2020; 78(2):179-188. doi:10.1016/j.pharma.2019.12.003,PMID:32037029.

[17] Petitet F. Interactions pharmacocinétiques entre préparation à base de plantes et médicament: une revue de l’importance Clinique. Phy-tothérapie 2012; 10(3):170-182. doi:10.1007/s10298-012-0705-2.

[18] Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regu-lation. Fitoterapia 2010; 81(6):462-471. doi:10.1016/j.fitote.2010.02.001,PMID:20156530.

[19] Muyumba NW, Mutombo SC, Sheridan H, Nachtergael A, Duez P. Quality control of herbal drugs and preparations: The meth-ods of analysis, their relevance and applications. Talanta Open 2021;4:100070. doi:10.1016/j.talo.2021.100070.

[20] George P. Concerns regarding the safety and toxicity of medicinal plants-An overview. J Appl Pharm Sci 2011; 1(6):40-44.

[21] Boullata JI, Nace AM. Safety issues with herbal medicine. Pharma-cotherapy 2000; 20(3):257-269. doi:10.1592/phco.20.4.257.34886,PMID:10730682.

[22] Ernst E. Herbal medicines: balancing benefits and risks. Novartis Found Symp 2007; 282:154-167. doi:10.1002/9780470319444.ch11,PMID:17913230.

[23] Gardner Z, McGuffin M, editors. American Herbal Products Associa-tion’s Botanical Safety Handbook. 2nd ed 2013; FloridaCRC Press.

[24] Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol 2015; 4(1):27-30. PMID:28197471.

[25] Ekor M. The growing use of herbal medicines: issues relating to ad-verse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:177. doi:10.3389/fphar.2013.00177,PMID:24454289.

[26] Ifeoma O, Oluwakanyinsola S. Screening of herbal medicines for po-tential toxicities. In: Gowder S (ed). New insights into toxicity and drug testing. Rijeka: IntechOpen; 2013:63-88. doi:10.5772/54493.

[27] Shaw D. Toxicological risks of Chinese herbs. Planta Med 2010; 76(17):2012-2018. doi:10.1055/s-0030-1250533,PMID:21077025.

[28] Msomi NZ, Simelane MB. Herbal medicine. In: Builders PF (ed). Herbal Medicine. Rijeka: IntechOpen; 2019:215-227. doi:10.5772/intechopen.72816.

[29] Mirzaeian R, Sadoughi F, Tahmasebian S, Mojahedi M. Progresses and challenges in the traditional medicine information system: A systematic review. J Pharm Pharmacogn Res 2019; 7(4):246-259. doi:10.56499/jppres19.662_7.4.246.

[30] Ahmad Khan MS, Ahmad I. Chapter 1-Herbal medicine: current trends and future prospects. In: Ahmad Khan MS, Ahmad I, Chat-topadhyay D (eds). New Look to Phytomedicine: Advancements in Herbal Products as Novel Drug Leads. Cambridge: Academic Press; 2019:3-13. doi:10.1016/B978-0-12-814619-4.00001-X.

[31] Wake GE, Fitie GW. Magnitude and Determinant Factors of Herbal Medicine Utilization Among Mothers Attending Their Antenatal Care at Public Health Institutions in Debre Berhan Town, Ethiopia. Front Public Health 2022;10:883053. doi:10.3389/fpubh.2022.883053,PMID:35570953.

[32] Rafieian-Kopaei M. Medicinal plants for renal injury preven-tion. J Renal Inj Prev 2013; 2(2):63-65. doi:10.12861/jrip.2013.21,PMID:25340130.

[33] Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medi-cine: insights from a focus-group study in Germany. BMC Comple-ment Altern Med 2018; 18(1):92. doi:10.1186/s12906-018-2160-6,PMID:29544493.

[34] Mulholland CA, Benford DJ. What is known about the safety of multi-vitamin-multimineral supplements for the generally healthy popula-tion? Theoretical basis for harm. Am J Clin Nutr 2007; 85(1):318S-322S. doi:10.1093/ajcn/85.1.318S,PMID:17209218.

[35] Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 1992; 326(18):1173-1177. doi:10.1056/NEJM199204303261801,PMID:1313547.

[36] Phua DH, Zosel A, Heard K. Dietary supplements and herbal medi-cine toxicities-when to anticipate them and how to manage them. Int J Emerg Med 2009; 2(2):69-76. doi:10.1007/s12245-009-0105-z,PMID:20157447.

[37] Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharma-col 1997; 37(4):344-350. doi:10.1002/j.1552-4604.1997.tb04312.x, PMID:9115061.

[38] Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002; 252(2):107-113. doi:10.1046/j.1365-2796.2002.00999.x, PMID:12190885.

[39] Yee SK, Chu SS, Xu YM, Choo PL. Regulatory control of Chinese Pro-prietary Medicines in Singapore. Health Policy 2005; 71(2):133-149. doi:10.1016/j.healthpol.2003.09.013,PMID:15607377.

[40] Ariffin SH, A Wahab I, Hassan Y, Abd Wahab MS. Adulterated Tra-ditional-Herbal Medicinal Products and Its Safety Signals in Malay-sia. Drug Healthc Patient Saf 2021; 13:133-140. doi:10.2147/DHPS.S305953,PMID:34135639.

[41] Al Lawati HA, Al Busaidi I, Kadavilpparampu AM, Suliman FO. Deter-mination of Common Adulterants in Herbal Medicine and Food Sam-ples using Core-shell Column Coupled to Tandem Mass Spectrom-etry. J Chromatogr Sci 2017; 55(3):232-242. doi:10.1093/chromsci/bmw175,PMID:27881492.

[42] Raviraja Shetty G, Harsha R. Adulteration in medicinal plants and herbal drugs. Int J Agric Sci 2021; 12(1):12-17. doi:10.53390/ijas.v12i1.4.

[43] Krapf R. Development of Cushing’s syndrome after use of a herbal remedy. Lancet 2002;360(9348):1884. doi:10.1016/S0140-6736(02) 11747-8, PMID:12480390.

[44] Chan CY, Ng SW, Ching CK, Mak TWL. Detection of 28 Corticoster-oids in Pharmaceutical and Proprietary Chinese Medicinal Products Using Liquid Chromatography-Tandem Mass Spectrometry. J Chro-matogr Sci 2021; 59(6):548-554. doi:10.1093/chromsci/bmaa140,PMID:33479748.

[45] Kloner RA, Goggin P, Goldstein I, Hackett G, Kirby MG, Osterloh I, et al. A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction. J Cardiovasc Pharmacol Ther 2018; 23(5):375-386. doi:10.1177/1074248418771896,PMID:29739235.

[46] Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitu-tion in North American herbal products. BMC Med 2013; 11:222. doi:10.1186/1741-7015-11-222,PMID:24120035.

[47] Letsyo E, Jerz G, Winterhalter P, Lindigkeit R, Beuerle T. Incidence of Pyrrolizidine Alkaloids in Herbal Medicines from German Retail Mar-kets: Risk Assessments and Implications to Consumers. Phytother Res 2017; 31(12):1903-1909. doi:10.1002/ptr.5935,PMID:28960556.

[48] Han JP, Li MN, Luo K, Liu MZ, Chen XC, Chen SL. Identification of Da-turae flos and its adulterants based on DNA barcoding technique. Yao Xue Xue Bao 2011; 46(11):1408-1412. PMID:22260038.

[49] Pandey R, Tiwari RK, Shukla SS. Omics: A newer technique in herbal drug standardization & quantification. J Young Pharm 2016; 8(2):76-81. doi:10.5530/jyp.2016.2.4.

[50] World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Ge-neva: World Health Organization; 2007.

[51] World Health Organization. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: World Health Organization; 2003.

[52] Liang YZ, Xie P, Chan K. Quality control of herbal medicines. J Chro-matogr B Analyt Technol Biomed Life Sci 2004; 812(1-2):53-70. doi:10.1016/j.jchromb.2004.08.041,PMID:15556488.

[53] Wang H, Chen M, Li J, Chen N, Chang Y, Dou Z, et al. Quality con-sistency evaluation of Kudiezi Injection based on multivariate statistical analysis of the multidimensional chromatographic fin-gerprint. J Pharm Biomed Anal 2020;177:112868. doi:10.1016/j.jpba.2019.112868, PMID:31539713.

[54] Nazim MD, Aslam M, Khatoon R, Asif M, Chaudhary SS. Physico-chemi-cal standardization of Hansraj (Adiantum capillus-Veneris). J Drug Deliv Ther 2018; 8(6-s):195-203. doi:10.22270/jddt.v8i6-s.2229.

[55] World Health Organization. Quality Control Methods for Medicinal Plant Materials. Geneva: World Health Organization; 1998.

[56] Deogade MS, Prasad KS. Standardization of wild Krushnatulasi (Oci-mum tenuiflorum Linn) leaf. Int J Ayurveda Res 2019; 10(1):52-61. doi:10.47552/ijam.v10i1.1172.

[57] Shaheen N, Imam S, Abidi S, Sultan RA, Azhar I, Mahmood ZA. Com-parative pharmacognostic evaluation and standardization of Capsi-cum annuum L.( red chili). Int J Pharm Sci Res 2018; 9(7):2807-2817. doi:10.13040/IJPSR.0975-8232.9(7).2807-17.

[58] Liu C, Guo DA, Liu L. Quality transitivity and traceability system of herbal medicine products based on quality markers. Phytomedi-cine 2018; 44:247-257. doi:10.1016/j.phymed.2018.03.006,PMID:29631807.

[59] Steinhoff B. Review: Quality of herbal medicinal products: State of the art of purity assessment. Phytomedicine 2019;60:153003. doi:10.1016/j.phymed.2019.153003,PMID:31327654.

[60] Zhang J, Wider B, Shang H, Li X, Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med 2012; 20(1-2):100-106. doi:10.1016/j.ctim.2011.09.004,PMID:22305255.

[61] Indrayanto G. Regulation and standardization of herbal drugs: Cur-rent status, limitation, challenge's and future prospective. Profiles Drug Subst Excip Relat Methodol 2024; 49:153-199. doi:10.1016/bs.podrm.2023.11.003,PMID:38423707.

[62] Rashid S, Zafar M, Ahmad M, Lone FA, Shaheen S, Sultana S, et al. Microscopic investigations and pharmacognostic techniques used for the standardization of herbal drug Nigella sativa L. Microsc Res Tech. 2018; 81(12):1443-1450. doi:10.1002/jemt.23110,PMID:30351462.

[63] Rashid S, Zafar M, Ahmad M, Lone FA, Shaheen S, Sultana S, et al. Microscopic investigations and pharmacognostic techniques used for the standardization of herbal drug Nigella sativa L. Microsc Res Tech. 2018; 81(12):1443-1450. doi:10.1002/jemt.23110,PMID:30351462.

[64] Fugh-Berman A. Herb-drug interactions. Lancet 2000;355(9198):134-138. doi:10.1016/S0140-6736(99)06457-0, PMID:10675182.

[65] Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geri-atr Soc 1996; 44(8):944-948. doi:10.1111/j.1532-5415.1996.tb01865.x, PMID:8708305.

[66] Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncol-ogy: focus on mechanisms of induction. Oncologist 2006; 11(7):742-752. doi:10.1634/theoncologist.11-7-742, PMID:16880233.

[67] Farkas D, Shader RI, von Moltke LL, Greenblatt DJ. Mechanisms and consequences of drug-drug interactions. In: Gad SC ed. Preclinical development handbook:ADME and biopharmaceuti-cal properties. New York: John Wiley & Sons, Inc; 2008:879-917. doi:10.1002/9780470249031.ch25.

[68] Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol 2012;3:69. doi:10.3389/fphar.2012.00069,PMID:22557968.

[69] Neergheen-Bhujun VS. Underestimating the toxicological chal-lenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int 2013; 2013:804086. doi:10.1155/2013/804086,PMID:24163821.

[70] Brown L, Heyneke O, Brown D, van Wyk JP, Hamman JH. Impact of traditional medicinal plant extracts on antiretroviral drug ab-sorption. J Ethnopharmacol 2008; 119(3):588-592. doi:10.1016/j.jep.2008.06.028, PMID:18640255.

[71] Patsalos PN, Perucca E. Clinically important drug interactions in epi-lepsy: interactions between antiepileptic drugs and other drugs. Lan-cet Neurol 2003;2(8):473-481. doi:10.1016/s1474-4422(03)00483-6, PMID:12878435.

[72] Coppola M, Mondola R. Potential action of betel alkaloids on posi-tive and negative symptoms of schizophrenia: a review. Nord J Psy-chiatry 2012; 66(2):73-78. doi:10.3109/08039488.2011.605172,PMID:21859398.

[73] Engelberg D, McCutcheon A, Wiseman S. A case of ginseng-induced mania. J Clin Psychopharmacol 2001; 21(5):535-537. doi:10.1097/00004714-200110000-00015,PMID:11593083.

[74] Borrelli F, Izzo AA. Herb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009; 11(4):710-727. doi:10.1208/s12248-009-9146-8,PMID:19859815.

[75] Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE. Clinical relevance of St. John’s wort drug interactions revisited. Br J Pharmacol 2020; 177(6):1212-1226. doi:10.1111/bph.14936,PMID:31742659.

[76] Yin OQ, Tomlinson B, Waye MM, Chow AH, Chow MS. Pharma-cogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004; 14(12):841-850. doi:10.1097/00008571-200412000-00007,PMID:15608563.

[77] Taki Y, Yokotani K, Yamada S, Shinozuka K, Kubota Y, Watanabe Y, et al. Ginkgo biloba extract attenuates warfarin-mediated anticoagula-tion through induction of hepatic cytochrome P450 enzymes by bilo-balide in mice. Phytomedicine 2012; 19(2):177-182. doi:10.1016/j.phymed.2011.06.020, PMID:21802929.

[78] Greenblatt DJ, Leigh-Pemberton RA, von Moltke LL. In vitro in-teractions of water-soluble garlic components with human cyto-chromes p450. J Nutr 2006; 136(3 Suppl):806S-809S. doi:10.1093/jn/136.3.806S,PMID:16484569.

[79] Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr 2008; 87(4):863-871. doi:10.1093/ajcn/87.4.863,PMID:18400708.

[80] Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol 2011; 7(3):267-286. doi:10.1517/17425255.2011.553189,PMID:21254874.

[81] Ferrati M, Maggi F, Spinozzi E. Rotenone: Advances on Resources, Biosynthetic Pathway, Bioavailability, Bioactivity, and Pharmacology. Handbook of Dietary Flavonoids. Springer; 2023.

[82] Takemura A, Gong S, Sato T, Kawaguchi M, Sekine S, Kazuki Y, et al. Evaluation of Parent- and Metabolite-Induced Mitochondrial Toxici-ties Using CYP-Introduced HepG2 cells. J Pharm Sci 2021; 110(9):3306-3312. doi:10.1016/j.xphs.2021.06.001,PMID:34097978.

[83] Suroowan S, Abdallah HH, Mahomoodally MF. Herb-drug interac-tions and toxicity: Underscoring potential mechanisms and forecast-ing clinically relevant interactions induced by common phytoconstit-uents via data mining and computational approaches. Food Chem Toxicol 2021;156:112432. doi:10.1016/j.fct.2021.112432,PMID:34293424.

[84] Petrovska BB. Historical review of medicinal plants’ usage. Pharma-cogn Rev 2012; 6(11):1-5. doi:10.4103/0973-7847.95849,PMID:22654398.

[85] Šantić Ž, Pravdić N, Bevanda M, Galić K. The historical use of me-dicinal plants in traditional and scientific medicine. Psychiatr Danub 2017; 29(Suppl 4):787-792. PMID:29278625.

[86] Yuan H, Ma Q, Ye L, Piao G. The Traditional Medicine and Mod-ern Medicine from Natural Products. Molecules 2016; 21(5):559. doi:10.3390/molecules21050559,PMID:27136524.

[87] Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med 2005; 2(4):465-473. doi:10.1093/ecam/neh140,PMID:16322803.

[88] Balkrishna A, Sharma S, Maity M, Tomer M, Singh R, Gohel V, et al. Di-vya-WeightGo combined with moderate aerobic exercise remediates adiposopathy, insulin resistance, serum biomarkers, and hepatic lipid accumulation in high-fat diet-induced obese mice. Biomed Pharmaco-ther 2023;163:114785. doi:10.1016/j.biopha.2023.114785,PMID:37137183.

[89] Balkrishna A, Gohel V, Pathak N, Tomer M, Rawat M, Dev R, et al. Anti-hyperglycemic contours of Madhugrit are robustly translated in the Caenorhabditis elegans model of lipid accumulation by regulating oxidative stress and inflammatory response. Front Endocrinol (Laus-anne) 2022;13:1064532. doi:10.3389/fendo.2022.1064532,PMID:36545334.

[90] Balkrishna A, Gohel V, Pathak N, Singh R, Tomer M, Rawat M, et al. Anti-oxidant response of lipidom modulates lipid metabolism in Caenorhabditis elegans and in OxLDL-induced human mac-rophages by tuning inflammatory mediators. Biomed Pharmacother 2023;160:114309. doi:10.1016/j.biopha.2023.114309,PMID:36709598.

[91] Sekhar AV, Gandhi DN, Rao NM, Rawal UD. An experimental and clinical evaluation of anti-asthmatic potentialities of Devadaru compound (DC). Indian J Physiol Pharmacol 2003; 47(1):101-107. PMID:12708131.

[92] Balkrishna A, Goswami S, Singh H, Gohel V, Dev R, Haldar S, et al. Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling. Front Pharmacol 2022;13:1024830. doi:10.3389/fphar.2022.1024830,PMID:36386162.

[93] Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind trial of an ayurvedic plant derived formulation for treat-ment of rheumatoid arthritis. J Rheumatol 2000; 27(6):1365-1372. PMID:10852255.

[94] Balkrishna A, Sakat SS, Joshi K, Paudel S, Joshi D, Joshi K, et al. Anti-Inflammatory and Anti-Arthritic Efficacies of an Indian Traditional Herbo-Mineral Medicine “Divya Amvatari Ras” in Collagen Anti-body-Induced Arthritis (CAIA) Mouse Model Through Modulation of IL-6/IL-1β/TNF-α/NFκB Signaling. Front Pharmacol 2019;10:659. doi:10.3389/fphar.2019.00659,PMID:31333447.

[95] Xiong H, Ding X, Wang H, Jiang H, Wu X, Tu C, et al. Tibetan medi-cine Kuan-Jin-Teng exerts anti-arthritic effects on collagen-induced arthritis rats via inhibition the production of pro-inflammatory cytokines and down-regulation of MAPK signaling pathway. Phy-tomedicine 2019; 57:271-281. doi:10.1016/j.phymed.2018.12.023,PMID:30802713.

[96] Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypo-cholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India 2001; 49:231-235. PMID:11225136.

[97] Kumar PU, Adhikari P, Pereira P, Bhat P. Safety and efficacy of Hartone in stable angina pectoris—an open comparative trial. J Assoc Physi-cians India 1999; 47(7):685-689. PMID:10778587.

[98] Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma lon-ga extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, pla-cebo-controlled trial. Inflammopharmacology 2016; 24(6):377-388. doi:10.1007/s10787-016-0289-9,PMID:27761693.

[99] Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of Non-alcoholic Fatty Liver Disease with Cur-cumin: A Randomized Placebo-controlled Trial. Phytother Res 2016; 30(9):1540-1548. doi:10.1002/ptr.5659,PMID:27270872.

[100] Arabnezhad L, Mohammadifard M, Rahmani L, Majidi Z, Ferns GA, Bahrami A. Effects of curcumin supplementation on vitamin D levels in women with premenstrual syndrome and dysmenorrhea: a rand-omized controlled study. BMC Complement Med Ther 2022; 22(1):19. doi:10.1186/s12906-022-03515-2,PMID:35065636.

[101] Shah S, Rath H, Sharma G, Senapati SN, Mishra E. Effectiveness of curcumin mouthwash on radiation-induced oral mucositis among head and neck cancer patients: A triple-blind, pilot randomised con-trolled trial. Indian J Dent Res 2020; 31(5):718-727. doi:10.4103/ijdr.IJDR_822_18,PMID:33433509.

[102] Uchio R, Kawasaki K, Okuda-Hanafusa C, Saji R, Muroyama K, Muro-saki S, et al. Curcuma longa extract improves serum inflammatory markers and mental health in healthy participants who are over-weight: a randomized, double-blind, placebo-controlled trial. Nutr J 2021; 20(1):91. doi:10.1186/s12937-021-00748-8,PMID:34774052.

[103] Radunz CL, Okuyama CE, Branco-Barreiro FCA, Pereira RMS, Diniz SN. Clinical randomized trial study of hearing aids effectiveness in as-sociation with Ginkgo biloba extract (EGb 761) on tinnitus improve-ment. Braz J Otorhinolaryngol 2020; 86(6):734-742. doi:10.1016/j.bjorl.2019.05.003, PMID:31300303.

[104] Nazarinasab M, Behrouzian F, Negahban S, Sadegh AM, Zeynali E. Investigating the efficacy of Ginkgo biloba on the cognitive function of patients undergoing treatment with electric shock: a double-blind clinical trial. J Med Life 2022; 15(12):1540-1547. doi:10.25122/jml-2021-0262,PMID:36762332.

[105] Sha RN, Tang L, Du YW, Wu SX, Shi HW, Zou HX, et al. Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of diz-ziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial. J Tradit Chin Med 2022; 42(1):83-89. doi:10.19852/j.cnki.jtcm.20211214.001, PMID:35294126.

[106] Pingali U, Nutalapati C, Koilagundla N, Taduri G. A randomized, dou-ble-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia. BMC Comple-ment Med Ther 2020; 20(1):281. doi:10.1186/s12906-020-03071-7,PMID:32933504.

[107] Pingali U, Sukumaran D, Nutalapati C. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflam-mation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study. Phytother Res 2020; 34(12):3226-3235. doi:10.1002/ptr.6771,PMID:32618037.

[108] Zadhoush R, Alavi-Naeini A, Feizi A, Naghshineh E, Ghazvini MR. The effect of garlic (Allium sativum) supplementation on the li-pid parameters and blood pressure levels in women with polycys-tic ovary syndrome: A randomized controlled trial. Phytother Res 2021; 35(11):6335-6342. doi:10.1002/ptr.7282,PMID:34496450.

[109] Alhashim M, Lombardo J. Effect of Topical Garlic on Wound Heal-ing and Scarring: A Clinical Trial. Dermatol Surg 2020; 46(5):618-627. doi:10.1097/DSS.0000000000002123,PMID:31490311.

[110] Choudhary PR, Jani RD, Sharma MS. Effect of Raw Crushed Garlic ( on Components of Metabolic Syndrome. J Diet Suppl 2018; 15(4):499-506. doi:10.1080/19390211.2017.1358233,PMID:28956671.

[111] Xu C, Mathews AE, Rodrigues C, Eudy BJ, Rowe CA, O’Donoughue A, et al. Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN 2018; 24:148-155. doi:10.1016/j.clnesp.2017.11.010,PMID:29576354.

[112] Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial. Eur J Clin Nutr 2013; 67(1):64-70. doi:10.1038/ejcn.2012.178,PMID:23169470.

[113] Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, et al. Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial. PLoS One 2013; 8(4):e61271. doi:10.1371/journal.pone.0061271,PMID:23613825.

[114] Jovanovski E, Lea-Duvnjak-Smircic, Komishon A, Au-Yeung F, Zurbau A, Jenkins AL, et al. Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinque-folius) administration in individuals with hypertension and type 2 diabetes: A randomized controlled trial. Complement Ther Med 2020;49:102338. doi:10.1016/j.ctim.2020.102338,PMID:32147072.

[115] Lin CH, Lin YA, Chen SL, Hsu MC, Hsu CC. American Ginseng Attenu-ates Eccentric Exercise-Induced Muscle Damage via the Modulation of Lipid Peroxidation and Inflammatory Adaptation in Males. Nutri-ents 2021; 14(1):78. doi:10.3390/nu14010078,PMID:35010953.

[116] Ghorbani Z, Mirghafourvand M, Farshbaf Khalili A, Javadzadeh Y, Shakouri SK, Dastranj Tabrizi A. The Effect of Panax ginseng on Geni-tourinary Syndrome in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Complement Med Res 2021; 28(5):419-426. doi:10.1159/000514944,PMID:33730722.

[117] Jung JH, Kang TK, Oh JH, Jeong JU, Ko KP, Kim ST. The Effect of Ko-rean Red Ginseng on Symptoms and Inflammation in Patients With Allergic Rhinitis. Ear Nose Throat J 2021; 100(suppl 5):712S-719 S. doi:10.1177/0145561320907172,PMID:32070136.

[118] Guiné RP, Gonçalves FJ. Bioactive Compounds in Some Culinary Aro-matic Herbs and Their Effects on Human Health. Mini Rev Med Chem 2016; 16(11):855-866. doi:10.2174/1389557516666160211120540,PMID:26864553.

[119] Stéphane FF, Jules BK, Batiha GE, Ali I, Bruno LN. Extraction of bio-active compounds from medicinal plants and herbs. In: El-Shemy HA (ed). Natural Medicinal Plants. Rijeka: IntechOpen; 2021:1-39. doi:10.5772/intechopen.98602.

[120] Chang YJ, Hsu SL, Liu YT, Lin YH, Lin MH, Huang SJ, et al. Gallic acid induces necroptosis via TNF-α signaling pathway in activated hepatic stellate cells. PLoS One 2015; 10(3):e0120713. doi:10.1371/journal.pone.0120713, PMID:25816210.

[121] Yan Y, Liu N, Hou N, Dong L, Li J. Chlorogenic acid inhibits hepatocel-lular carcinoma in vitro and in vivo. J Nutr Biochem 2017; 46:68-73. doi:10.1016/j.jnutbio.2017.04.007,PMID:28458139.

[122] Liu H, Wang C, Qiao Z, Xu Y. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharm Biol 2017; 55(1):1144-1148. doi:10.1080/13880209.2016.1214741,PMID:28224816.

[123] Lv X, Xu T, Wu Q, Zhou Y, Huang G, Xu Y, et al. 6-Gingerol Acti-vates PI3K/Akt and Inhibits Apoptosis to Attenuate Myocardial Is-chemia/Reperfusion Injury. Evid Based Complement Alternat Med 2018; 2018:9024034. doi:10.1155/2018/9024034,PMID:29743926.

[124] Pal HC, Sharma S, Strickland LR, Agarwal J, Athar M, Elmets CA, et al. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signal-ing pathways. PLoS One 2013; 8(10):e77270. doi:10.1371/journal.pone.0077270, PMID:24124611.

[125] Wang X, Zhang ZF, Zheng GH, Wang AM, Sun CH, Qin SP, et al. The Inhibitory Effects of Purple Sweet Potato Color on Hepatic Inflam-mation Is Associated with Restoration of NAD+ Levels and Attenu-ation of NLRP3 Inflammasome Activation in High-Fat-Diet-Treated Mice. Molecules 2017; 22(8):1315. doi:10.3390/molecules22081315,PMID:28786950.

[126] Zapf MA, Kothari AN, Weber CE, Arffa ML, Wai PY, Driver J, et al. Green tea component epigallocatechin-3-gallate decreases expres-sion of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma. Surgery 2015; 158(4):1039-1047. doi:10.1016/j.surg.2015.06.011,PMID:26189955.

[127] Sur S, Pal D, Roy R, Barua A, Roy A, Saha P, et al. Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice. Toxicol Appl Pharmacol 2016; 300:34-46. doi:10.1016/j.taap.2016.03.016,PMID:27058323.

[128] Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, et al. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett 2008; 262(1):10-18. doi:10.1016/j.canlet.2007.11.026,PMID:18164805.

[129] Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duang-nil N, Kongtawelert P.Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochon-drial and death receptor pathways. Tumour Biol 2016; 37(1):227-237. doi:10.1007/s13277-015-3774-7,PMID:26194866.

[130] Zhang J, Song J, Wu D, Wang J, Dong W. Hesperetin induces the apo-ptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium. Med Oncol 2015; 32(4):101. doi:10.1007/s12032-015-0516-z,PMID:25737432.

[131] Yen HR, Liu CJ, Yeh CC. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in hu-man hepatocellular carcinoma cells. Chem Biol Interact 2015; 235:1-9. doi:10.1016/j.cbi.2015.04.003, PMID:25866363.

[132] Akram M, Riaz M, Wadood AWC, Hazrat A, Mukhtiar M, Ahmad Zak-ki S, et al.Medicinal plants with anti-mutagenic potential. Biotechnol Biotechnol Equip 34(1):309-318. doi:10.1080/13102818.2020.1749527.

[133] García ER, Gutierrez EA, de Melo FCSA, Novaes RD, Gonçalves RV. Flavonoids Effects on Hepatocellular Carcinoma in Murine Mod-els: A Systematic Review. Evid Based Complement Alternat Med 2018; 2018:6328970. doi:10.1155/2018/6328970,PMID:29681978.

[134] Iyer SC, Gopal A, Halagowder D. 1 (PAK1) signaling cascade in hepa-tocellular carcinoma. Mol Cell Biochem 2015; 407(1-2):223-237. doi:10.1007/s11010-015-2471-6,PMID:26104578.

[135] Kim SJ, Jeong CW, Bae HB, Kwak SH, Son JK, Seo CS, et al. Protec-tive effect of sauchinone against regional myocardial ischemia/reperfusion injury: inhibition of p38 MAPK and JNK death signal-ing pathways. J Korean Med Sci 2012; 27(5):572-575. doi:10.3346/jkms.2012.27.5.572,PMID:22563228.

[136] Zuo YH, Liu YB, Cheng CS, Yang YP, Xie Y, Luo P, et al. Isovaleroylb-inankadsurin A ameliorates cardiac ischemia/reperfusion injury through activating GR dependent RISK signaling. Pharmacol Res 2020;158:104897. doi:10.1016/j.phrs.2020.104897,PMID:32422343.

[137] Zhang H, Sun Q, Xu T, Hong L, Fu R, Wu J, et al. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways. Mol Med Rep 2016; 13(1):224-230. doi:10.3892/mmr.2015.4497,PMID:26530037.

[138] Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, et al. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial ac-tivated apoptosis and ameliorates the development of liver fibro-sis in rats. J Ethnopharmacol 2011; 137(1):714-723. doi:10.1016/j.jep.2011.06.030, PMID:21726622.

[139] Ling Y, Chen G, Deng Y, Tang H, Ling L, Zhou X, et al. Polydatin post-treatment alleviates myocardial ischaemia/reperfusion injury by promoting autophagic flux. Clin Sci (Lond) 2016; 130(18):1641-1653. doi:10.1042/CS20160082,PMID:27340138.

[140] Mioc M, Milan A, Malița D, Mioc A, Prodea A, Racoviceanu R, et al. Recent Advances Regarding the Molecular Mechanisms of Trit-erpenic Acids: A Review (Part I). Int J Mol Sci 2022; 23(14):7740. doi:10.3390/ijms23147740,PMID:35887090.

[141] Yi C, Song M, Sun L, Si L, Yu D, Li B, et al. Asiatic Acid Alleviates Myo-cardial Ischemia-Reperfusion Injury by Inhibiting the ROS-Mediated Mitochondria-Dependent Apoptosis Pathway. Oxid Med Cell Longev 2022; 2022:3267450. doi:10.1155/2022/3267450,PMID:35198095.

[142] Wang F, Gao Q, Yang J, Wang C, Cao J, Sun J, et al. Artemisinin sup-presses myocardial ischemia-reperfusion injury via NLRP 3 inflam-masome mechanism. Mol Cell Biochem 2020; 474(1-2):171-180. doi:10.1007/s11010-020-03842-3,PMID:32729005.

[143] Chang L, Shi R, Wang X, Bao Y. Gypenoside A protects ischemia/reperfusion injuries by suppressing miR-143-3p level via the acti-vation of AMPK/Foxo1 pathway. Biofactors 2020; 46(3):432-440. doi:10.1002/biof.1601,PMID:31889343.

[144] Wang Y, Che J, Zhao H, Tang J, Shi G. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reox-ygenation injury. Biochem Biophys Res Commun 2018; 503(4):3219-3224. doi:10.1016/j.bbrc.2018.08.129,PMID:30146261.

[145] Omata M, Matsui N, Inomata N, Ohno T. Protective effects of polysac-charide fucoidin on myocardial ischemia-reperfusion injury in rats. J Cardiovasc Pharmacol 1997; 30(6):717-724. doi:10.1097/00005344-199712000-00003,PMID:9436808.

[146] Przybylska S, Tokarczyk G. Lycopene in the Prevention of Car-diovascular Diseases. Int J Mol Sci 2022; 23(4):1957. doi:10.3390/ijms23041957,PMID:35216071.

[147] Wang XY, Dong WP, Bi SH, Pan ZG, Yu H, Wang XW, et al. Protec-tive effects of osthole against myocardial ischemia/reperfusion injury in rats. Int J Mol Med 2013; 32(2):365-372. doi:10.3892/ijmm.2013.1386,PMID:23695269.